Genfit S.A. (GNFT)
NASDAQ: GNFT · IEX Real-Time Price · USD
4.465
+0.245 (5.81%)
Jul 22, 2024, 9:54 AM EDT - Market open
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
$266,778
Profits / Employee
-$201,915
Market Cap
219.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Joint | 794 |
bluebird bio | 323 |
Biodesix | 217 |
CVRx, Inc. | 200 |
Century Therapeutics | 165 |
Caribou Biosciences | 158 |
Shattuck Labs | 75 |
GNFT News
- 12 days ago - GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire
- 4 weeks ago - GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH - GlobeNewsWire
- 5 weeks ago - GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis - GlobeNewsWire
- 5 weeks ago - US FDA approves Genfit and Ipsen's liver disease drug - Reuters
- 7 weeks ago - GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 - GlobeNewsWire
- 2 months ago - GENFIT: May 22, 2024 Combined Shareholders Meeting Results - GlobeNewsWire
- 2 months ago - GENFIT Reports First Quarter 2024 Financial Information - GlobeNewsWire
- 3 months ago - GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) - GlobeNewsWire